hepatx.com Open in urlscan Pro
198.49.23.144  Public Scan

Submitted URL: http://hepatx.com/
Effective URL: https://hepatx.com/
Submission: On October 09 via api from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

ABOUT HEPATX
STRATEGY
TEAM
CAREERS
SCIENCE
MEDIA
CONTACT US
ABOUT HEPATX
STRATEGY
TEAM
CAREERS
SCIENCE
MEDIA
CONTACT US
ABOUT HEPATX
STRATEGY
TEAM
CAREERS
SCIENCE
MEDIA
CONTACT US
 
 


OFF-THE-SHELF CELL THERAPIES FOR LIVER DISEASE.

 


USING REGENERATIVE MEDICINE TECHNOLOGIES, HEPATX IS DEVELOPING NEW TYPES OF
TREATMENTS, BASED ON STEM CELLS, TO BRING NEW THERAPIES TO PATIENTS WITH LATE
STAGE LIVER DISEASE, AS AN ALTERNATIVE TO LIVER TRANSPLANT. 

Over 30 million Americans suffer with liver disease. Of those, 200,000 people
each year develop end-stage liver failure and will require an organ transplant
to survive.

Despite the $8.5 billion spent annually on patient care and facilitating this
procedure,

 



ONLY 1 IN 33 RECEIVE THE TRANSPLANT THAT WILL SAVE THEIR LIFE.



In this arena that is literally a matter of life or death, we are no longer
asking ourselves ‘Will we revolutionize liver disease treatment?’

Instead, we’ve directed our undivided attention to discovering HOW.

 

Breakthrough Therapeutics

Thousands of patients die in waiting for costly, limited liver care.
The HepaTx team knew we could do better.

UNDERSTAND THE SCIENCE

Optimal Market Positioning

Our scalable manufacturing process makes liver regeneration
both clinically and economically practical.

LEARN MORE ABOUT HEPATX

Curated Team of Experts

We’re honored to devote our decades of experience
to the long-overdue evolution of liver care.

GET TO KNOW US




WE ARE PROUD TO COLLABORATE WITH A COMMUNITY OF TRUE ENTREPRENEURIAL PIONEERS.

 
 

 


AND OUR DISTINGUISHED INVESTORS GIVE OUR TECHNOLOGY TRACTION AND STAYING POWER.

 
 

 
 


HEPATX IS ON A MISSION TO EDUCATE THE WORLD ON OUR EFFECTIVE, ACCESIBLE
ALTERNATIVE TO LIVER TRANSPLANT. FOLLOW US IN THE NEWS…

 
 


JOIN OUR MISSION TO BRING REGENERATIVE MEDICINE-BASED THERAPIES TO THOUSANDS OF
PATIENTS IN NEED OF LIVER TRANSPLANT.

CONTRIBUTE TO THE SOLUTION
 
 

 

HepaTx Awarded 2022 Impact Company of The Year Award by DotCom Magazine
| READ MORE | Feb 15, 2022

 
 

--------------------------------------------------------------------------------

 

Interested in learning about Investment or Career Opportunities with HepaTx?
We’d love to hear from you. Please get in touch…

Back To Top

HepaTx Corporation
Palo Alto, CA

ABOUT HEPATX
SCIENCE
MEDIA
CONTACT US